The funding will be used to complete the Phase II/III trial of ulviprubart, and to support commercial launch preparation.

Explore how IBM’s approach to AI development differs from its competitors. Learn why the company is winning the enterprise AI ...

Riyadh, Saudi Arabia – Diriyah Company, the developer behind Saudi Arabia’s ambitious 14sq km City of Earth urban development ...

Funding was led by New Enterprise Associates, with participation from Foresite Capital and multiple other investors.

Collaboration to offer Saudi Arabia-specific client solutions comprised of generative AI products from IBM watsonx portfolio ...

Oppenheimer initiated coverage of IBM (IBM) with an Outperform rating and $320 price target The firm’s bullish stance is based on the view ...

Fintel reports that on February 11, 2025, Oppenheimer initiated coverage of International Business Machines (NYSE:IBM) with a ...

A remarkable 89 per cent of surveyed companies have already launched more than 10 AI pilot projects in 2024, according to new ...

DOGE officials have been active at USAID, Veterans Affairs, Treasury and elsewhere, but little is publicly known about their ...

On January 30, 2025, IBM Research hosted a tour at its Yorktown Heights headquarters, discussing the latest advancements in artificial intelligence (AI), quantum computing, semiconductor technology, ...

Abcuro, Inc., a clinical-stage biotechnology company developing therapies for the treatment of autoimmune diseases and cancer through precise modulation of cytotoxic T cells, today announced the ...

The bank expects new hires for its quantum team to be based in Chicago, where plans to build the nation’s first utility-scale ...